首页> 外文会议>International Headache Research Seminar >meta-Chloro-phenylpiperazine as an agent for provoking cluster headache attacks: a study versus placebo
【24h】

meta-Chloro-phenylpiperazine as an agent for provoking cluster headache attacks: a study versus placebo

机译:Meta-Chloro-phenylpipHiperazine作为用于引发群集头痛攻击的药剂:一项研究与安慰剂

获取原文

摘要

Meta-Chlorophenylpiperazine fmCPP) is a 5HT2/ja receptor agonist that induces migraine-like headaches.1 We were the first to report the occurrence of mCPP-related cluster headache attacks in cluster headache patients2 in the cluster period. The advantages of employing mCPP as a cluster headache attack trigger are:mCPP acts through the selective stimulation of 5HT_(2/1A) receptors.it is possible that mCPP plasma levels correlate with observed clinical events during the study period.To further investigate the role of 5HT_(2/1A) receptors in triggering cluster headache attacks, we administered mCPP and placebo to a larger group of cluster headache patients in both cluster period and remission.
机译:Meta-氯苯基哌嗪FMCPP)是5HT2 / JA受体激动剂,诱导偏头痛的头痛.1我们是第一个报告在聚类期间群体头痛患者中的MCPP相关群体头痛攻击的发生。使用MCPP作为簇头痛攻击触发的优点是:MCPP通过选择性刺激5HT_(2 / 1A)受体。对于在研究期间,MCPP等级可以与观察到的临床事件相关。进一步调查该角色在5HT_(2/1A)的受体中触发簇头痛攻击,我们将MCPP和安慰剂提供给一组聚类期间和缓解的较大群体头痛患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号